ஆரோன் ரிடர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆரோன் ரிடர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆரோன் ரிடர் Today - Breaking & Trending Today

Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer's Drug


Jul 12, 2021
As physicians and health policy experts debate the merits of Aduhelm, the first new drug for Alzheimer’s disease approved in 18 years, patients want to know: “Will this medication help me and how much?”
Doctors explaining the pros and cons of Aduhelm won’t have a definitive answer. “On an individual basis, it will be absolutely impossible to predict,” said Dr. Allan Levey, director of the Goizueta Alzheimer’s Disease Research Center at Emory University.
Cognitive decline varies widely among people who have started experiencing memory and thinking problems or who are in the earliest stage of Alzheimer’s the patients in whom Aduhelm was tested, Levey noted. ....

New York , United States , Mount School , Las Vegas , Henry Paulson , Judith Graham , Samuel Gandy , Allan Levey , Aaron Ritter , Jason Karlawish , Maria Torroella Carney , G Caleb Alexander , Michigan Alzheimer Disease Center , University Of Pennsylvania Perelman School Medicine , Northwell Health , Eisai Inc , Kaiser Family Foundation , Mount Sinai Icahn School Of Medicine , Brain Health In Las Vegas , Cleveland Clinic Lou Ruvo Center , University Of Michigan , Drug Administration On , Johns Hopkins Center , Kaiser Health News , University Of Pennsylvania , Penn Memory Center ,

Doctores sopesan pros y contras de recetar la nueva droga para el Alzheimer


Por Judith Graham
Mientras médicos y expertos en políticas de salud debaten los méritos de Aduhelm, el primer fármaco para el Alzheimer aprobado en 18 años, los pacientes simplemente quieren saber: “¿me ayudará?”.
Alzheimer’s Greater Los Angeles is a local, dementia-focused nonprofit with five locations in Southern California. (Heidi de Marco/KHN)
Los médicos no tienen una respuesta definitiva. “En cada persona, será absolutamente imposible de predecir”, dijo el doctor Allan Levey, director del Centro de Investigación de la Enfermedad de Alzheimer Goizueta, en la Universidad Emory.
El deterioro cognitivo varía ampliamente entre las personas que han comenzado a experimentar problemas de memoria y pensamientos, o que se encuentran en la etapa más temprana del Alzheimer, los pacientes en los que se evaluó Aduhelm, apuntó Levey. ....

New York , United States , Samuel Gandy , Henry Paulson , Caleb Aleksander , Allan Levey , Aaron Ritter , Las Vegas , School Of Medicine Perelman , Eisai Inc , Centre Johns Hopkins , University Of Michigan , Centre For Research , School Of Medicine To Mount Sinai Icahn , Centre For Disease Alzheimer Of Michigan , Administration Of Food , Penn Memory Center , University Of Pennsylvania , University Emory , Centre Of The Clinic Lou Ruvo Cleveland , Judith Graham While , Medicine Perelman , Mount Sinai Icahn , Disease Alzheimer , Medicare Pays , Clinic Lou Ruvo Cleveland ,